CompletedNot Applicable

Complication of Pancreatic Fistula and Bleeding After Pancreaticoduodenectomy in Treatment Periampullary Cancer

Vietnam183 participantsStarted 2021-08-01

Plain-language summary

This multi-site study will be done across Hepatobiliary and Pancreatic Surgery Department at Cho Ray Hospital and University and Pharmacy Center. Patients who are diagnosed with periampullary cancer from August 2021 to August 2023 will be underwent pancreaticoduodenectomy. We will follow-up for their pancreatic fistula and bleeding complication and analysis some risk factors.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients diagnosed with periampullary cancer meet the following criteria: * Possibility to perform pancreaticoduodenectomy based on preoperative imaging and intraoperative exploration. * The postoperative pathology is adenocarcinoma (of the ampulla of Vater, common bile duct, duodenum or pancreas) Exclusion Criteria: * The patient has other organ's cancer beyond periampullary cancer. * Patient's medical conditions contraindicate for anesthesia. * The patient does not consent to participate in the study

What they're measuring

Pancreatic fistula

Timeframe: 90 post-operative days

Trial details

NCT IDNCT04985071

SponsorVo Truong Quoc

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-10-31

View on ClinicalTrials.gov More Periampullary Cancer trials